<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03819400</url>
  </required_header>
  <id_info>
    <org_study_id>RIPH3-RNI18-Elastogreffe</org_study_id>
    <nct_id>NCT03819400</nct_id>
  </id_info>
  <brief_title>Evaluation of Kidney Graft's Fibrosis With Real Time Shear-wave Elastography</brief_title>
  <acronym>Elastogreffe</acronym>
  <official_title>Evaluation of Kidney Graft's Fibrosis With Real Time Shear-wave Elastography</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Tours</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Tours</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Kidney graft's fibrosis is correlated with prognostic of kidney's graft, wathever the initial&#xD;
      etiology. Actually, that evaluation is based on histologic score of Banff FI/AT (0 to III).&#xD;
      It is obtained thanks to punction-biopsy, which is invasive and can lead complications. This&#xD;
      exam is systematic on M3 of the transplantation.&#xD;
&#xD;
      Tissue's fibrosis is a proliferation of extracellular matrix, leading to an increase of&#xD;
      fibrosed tissue rigidity.&#xD;
&#xD;
      Elastography is an ultrasound technique allowing evaluation of tissues' rigidity.&#xD;
&#xD;
      The purpose is the validation of elastograhpy, innovative and non -invasive technique, and&#xD;
      more specifically Shear Wave Elastography (SWE). For this, strain ratio (SR) could improve&#xD;
      intra-operator variability and estimate fibrosis' degree of kidney's graft.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Kidney graft's fibrosis is correlated with prognostic of kidney's graft, wathever the initial&#xD;
      etiology. Actually, that evaluation is based on histologic score of Banff FI/AT (0 to III).&#xD;
      It is obtained thanks to punction-biopsy, which is invasive and can lead complications. This&#xD;
      exam is systematic on M3 of the transplantation.&#xD;
&#xD;
      Tissue's fibrosis is a proliferation of extracellular matrix, leading to an increase of&#xD;
      fibrosed tissue rigidity.&#xD;
&#xD;
      Elastography is an ultrasound technique allowing evaluation of tissues' rigidity.&#xD;
&#xD;
      The purpose is the validation of elastograhpy, innovative and non -invasive technique, and&#xD;
      more specifically Shear Wave Elastography (SWE). For this, strain ratio (SR) could improve&#xD;
      intra-operator variability and estimate fibrosis' degree of kidney's graft.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 29, 2019</start_date>
  <completion_date type="Anticipated">March 2022</completion_date>
  <primary_completion_date type="Anticipated">December 25, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>measure of shear wave elastography</measure>
    <time_frame>3 months</time_frame>
    <description>Evaluation of shear wave elastography real time as biomarker of kidney graft's fibrosis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Strain Ratio measure</measure>
    <time_frame>3 months</time_frame>
    <description>- Intra-operator variability of Strain Ratio measure</description>
  </secondary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Kidney Graft</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Kidney-transplanted patient&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Kidney-transplanted patient, whatever kind of organ donation ( alive donor, deceased&#xD;
             donor included extended criteria Maastricht 2 or 3)&#xD;
&#xD;
          -  More than 18 years-old&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Dual kidney graft&#xD;
&#xD;
          -  Hydronephrosis / urinary obstacle&#xD;
&#xD;
          -  Pathologies with an intrinsic compression on the graft&#xD;
&#xD;
          -  Stenosis hemodynamically significant of graft artery (lengthening of Systolic Ascent&#xD;
             Time &gt; 70 ms)&#xD;
&#xD;
          -  Contra-indication to systematical punction-biopsy on Month 3 :&#xD;
&#xD;
               -  Ischemia of post-transplanted graft&#xD;
&#xD;
               -  Alive donor HLA identical&#xD;
&#xD;
               -  Hemostasis disorder or unable to stop antiaggregant or anticoagulant&#xD;
&#xD;
               -  Hydronephrosis / urinary obstacle&#xD;
&#xD;
          -  Opposition to use the data&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Corneliu Gradinaru, MD</last_name>
    <phone>02 47 38 67 92</phone>
    <email>c.gradinaru@chu-tours.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Chu Tours</name>
      <address>
        <city>Tours</city>
        <zip>37044</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Corneliu GRADINARU, MD</last_name>
      <email>c.gradinaru@chu-tours.fr</email>
    </contact>
    <investigator>
      <last_name>Corneliu GRADINARU, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>January 25, 2019</study_first_submitted>
  <study_first_submitted_qc>January 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 28, 2019</study_first_posted>
  <last_update_submitted>October 4, 2021</last_update_submitted>
  <last_update_submitted_qc>October 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>kidney graft</keyword>
  <keyword>fibrosis</keyword>
  <keyword>elastography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibrosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

